Modulation of antigen-specific T and B cell responses influence bacterial clearance of non-typeable Haemophilus influenzae from the lung in a rat model

Vaccine

Volumn 14, Issue 15, 1996, Pages 1471-1478

  Kyd, Jennelle M ^a   Cripps, Allan W ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Immune response; Non typeable Haemophilus influenzae; P2; Pulmonary clearance

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HUMORAL IMMUNITY; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; LUNG; MALE; RATS; T-LYMPHOCYTES;

EID: 0030458751     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00034-5     Document Type: Article

References (42)

1. 1 Barenkamp, S.J., Munson, R.S.Jr and Granoff, D.M. Outer membrane protein and biotype analysis of pathogenic nontypeable Haemophilus influenzae. Infect. Immun. 1982, 36, 535-540
2. 2 Loeb, M.R. and Smith, D.H. Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect. Immun. 1980, 30, 709-717
3. 3 Murphy, T.F. and Apicella, M.A. Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system. Infect. Immun. 1985, 50, 15-21
4. 4 Barenkamp, S.J., Granoff, D.M. and Munson, R.S.Jr Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centres. J. Infect. Dis. 1981, 144, 210-217
5. 5 Groeneveld, K., van Alphen, L., Voorter, C., Eijk, P.P., Jansen, H.M., Zanen, H.C. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect. Immun. 1989, 57, 3038-3044
6. 6 Haase, E.M., Campagnari, A.A., Sarwar, J. et al. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect. Immun. 1991, 59, 1278-1284
7. 7 Duim, B., Dankert, J., Jansen, H.M. and van Alphen, L. Genetic analysis of the diversity in outer membrane P2 of non-encapsulated Haemophilus influenzae. Microb. Pathog. 1993, 14, 451-462
8. 8 Bell, J., Grass, S., Jeanteur, D. and Munson, R.S. Jr Diversity of the P2 protein among nontypeable Haemophilus influenzae isolates. Infect. Immun. 1994, 62, 2639-2643
9. 9 Haase, E.M., Yi, K., Morse, G.D. and Murphy, T.F. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect. Immun. 1994, 62, 3712-3722
10. 10 Branfors, P. and Dahlberg, T. Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae. APMIS 1980, 88, 47-56
11. 11 Gnehm, H.E., Pelton, S.I., Gulati, S. and Rice, P.A. Characterization of antigens from nontypeable Haemophilus influenzae recognized by human bactericidal antibodies. J. Clin. Invest. 1985, 75, 1645-1658
12. 12 Harada, T., Sakakura, Y. and Miyoshi, Y. Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae in chronic sinusitis. Arch. Otorhinolaryngol. 1984, 240, 79-83
13. 13 Murphy, T.F. and Bartos, L.C. Human bactericidal antibody response to outer membrane P2 of nontypable Haemophilus influenzae. Infect. Immun. 1988, 56, 2673-2679
14. 14 Murphy, T.F., Bartos, L.C., Rice, P.A., Nelson, M.B., Dudas, K.C. and Apicella, M.A. Identification of a 16,600-Dalton outer membrane protein on nontypable Haemophilus influenzae as a target for human serum bactericidal antibody. J. Clin. Invest. 1986, 78, 1020-1027
15. 15 Musher, D.M., Hague-Park, M., Baughn, R.E., Wallace, R.J. Jr and Cowley, B. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect. Immun. 1983, 39, 297-304
16. 16 Bernstein, J.M., Faden, H.S., Loos, B.G., Murphy, T.F. and Ogra, P.L. Recurrent otitis media with non-typable Haemophilus influenzae: the role of serum bactericidal antibody. Int. J. Pediatr. Otorhinolaryngol. 1992, 23, 1-13
17. 17 Harabuchi, Y., Faden, H., Yamanaka, N., Duffy, L., Wolf, J. and Krystofik, D. Human milk secretory IgA antibody to nontypeable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization. J. Pediatr. 1994, 124, 193-198
18. 18 Yamanaka, N. and Faden, H. Local antibody response to P6 of nontypable Haemophilus influenzae in otitis-prone and normal children. Acta Otolaryngol. 1993, 113, 524-529
19. 19 McGhee, J.R. and Kiyono, H. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 1993, 2, 55-73
20. 20 Wallace, F.J., Cripps, A.W., Clancy, R.L., Husband, A.J. and Witt, C.S. A role for intestinal T lymphocytes in bronchus mucosal immunity. Immunology 1991, 74, 68-73
21. + T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung. Immunology 1994, 83, 362-369
22. 22 Kyd, J.M., Taylor, D. and Cripps, A.W. Conservation of immune responses to proteins isolated by preparative-PAGE from the outer membrane of nontypable Haemophilus influenzae. Infect. Immun. 1994, 62, 5652-5658
23. 23 Murphy, T.F. and Bartos, L.C. Purification and analysis with monoclonal antibodies of P2, the major outer membrane protein of nontypable Haemophilus influenzae. Infect. Immun. 1988, 56, 1084-1089
24. 24 Suzuki, H. and Terada, T. Removal of dodecyl sulfate from protein solution. Anal. Biochem. 1988, 172, 259-263
25. 25 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685
26. 26 Wallace, F.J., Clancy, R.L. and Cripps, A.W. An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from respiratory tract after antigen stimulation of gut-associated lymphoid tissue. Am. Rev. Respir. Dis. 1989, 140, 311-316
27. 27 Kyd, J.M., Dunkley, M.L. and Cripps, A.W. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect. Immun. 1995, 63, 2931-2940
28. 28 Wysocki, L.J. and Sato, V.L. Panning for lymphocytes: a method for cell selection. Proc. Natl. Acad. Sci. USA 1978, 75, 2844-2848
29. 29 Yi, K. and Murphy, T.F. Mapping of a strain-specific epitope to the surface-exposed loop 5 on the P2 porin protein of nontypeable Haemophilus influenzae. Microbial. Pathogesis 1994, 17, 277-282
30. 30 Rock, K.L., Benacerraf, B. and Abbas, A.K. Antigen presentation by hapten-specific B lymphocytes. I Role of surface immunoglobulin receptors. J. Exp. Med. 1984, 160, 1102
31. 31 Ron, Y. and Sprent, J. T cell priming in vitro: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immun. 1987, 138, 2848
32. 32 McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
33. 33 Michetti, P., Mahan, M.J., Slauch, J.M., Mekalanos, J.J. and Neutra, M.R. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect. Immun. 1992, 60, 1786-1792
34. 34 Berger, M. Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J. Pediatr. 1987, 110, 325-328
35. 35 Finkelman, F.D., Holmes, J., Katona, I.M. et al. Lymphokine control of in vivo immunoglobulin isotype selection. A. Rev. Immun. 1990, 8, 303-333
36. 36 Kiyono, H., Bienenstock, J., McGhee, J.R. and Ernst, P.B. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development. Reg. Immun. 1992, 4, 54-62
37. 37 Mosmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. A. Rev. Immun. 1989, 7, 145-173
38. 38 Wallace, F.J., Witt, C.S., Clancy, R.L. and Cripps, A.W. Protection against non-typeable Haemophilus influenzae following sensitization of gut associated lymphoid tissue: role of specific antibody and phagocytes. Immunol. Cell Biol. 1995, 73, 258-265
39. 39 Gregoriadis, G. Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. Res. Immun. 1992, 143, 178-185
40. 40 Jiskoot, W., Teerlink, T., van Hoof, M.M.M., Bartels, K., Kanhai, V. and Crommelin, D.J.A. Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes. Infect. Immun. 1986, 54, 333-338
41. 41 Bartlett, W.C., Michael, A., McCann, J., Yuan, D., Claasen, E. and Noelle, R.J. Cognate interactions between helper T cells and B cells. J. Immun. 1989, 143, 1745-1754
42. 42 Noelle, R.J., Daum, J., Bartlett, W.C., McCann, J. and Shepherd, D.M. Cognate interactions between helper T cells and B cells. V. Reconstitution of T helper cell function using purified plasma membranes from activated Th1 and Th2 helper cells and lymphokines. J. Immun. 1991, 146, 1118-1124